🚀 VC round data is live in beta, check it out!
Diagnósticos da América Valuation Multiples
Discover revenue and EBITDA valuation multiples for Diagnósticos da América and similar public comparables like Butterfly Network, Clinica Baviera, Novogene, BioLife Solutions and more.
Diagnósticos da América Overview
About Diagnósticos da América
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
Founded
1961
HQ
Employees
18.1K
Website
Financials (LTM)
EV
$2B
Diagnósticos da América Financials
Diagnósticos da América reported last 12-month revenue of $2B and EBITDA of $431M.
In the same LTM period, Diagnósticos da América generated $431M in EBITDA and had net loss of ($77M).
Revenue (LTM)
Diagnósticos da América P&L
In the most recent fiscal year, Diagnósticos da América reported revenue of $3B and EBITDA of $419M.
Diagnósticos da América expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $797M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 27% | XXX | XXX | XXX |
| EBITDA | $431M | XXX | $419M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 13% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | ($77M) | XXX | ($199M) | XXX | XXX | XXX |
| Net Margin | (4%) | XXX | (7%) | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Diagnósticos da América Stock Performance
Diagnósticos da América has current market cap of $957M, and enterprise value of $2B.
Market Cap Evolution
Diagnósticos da América's stock price is $0.77.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $957M | (0.6%) | XXX | XXX | XXX | $-0.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDiagnósticos da América Valuation Multiples
Diagnósticos da América trades at 1.2x EV/Revenue multiple, and 5.4x EV/EBITDA.
EV / Revenue (LTM)
Diagnósticos da América Financial Valuation Multiples
As of March 7, 2026, Diagnósticos da América has market cap of $957M and EV of $2B.
Equity research analysts estimate Diagnósticos da América's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Diagnósticos da América has a P/E ratio of (12.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $957M | XXX | $957M | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 5.4x | XXX | 5.6x | XXX | XXX | XXX |
| EV/EBIT | 9.0x | XXX | 11.5x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.9x | XXX | XXX | XXX |
| P/E | (12.4x) | XXX | (4.8x) | XXX | XXX | XXX |
| EV/FCF | 23.3x | XXX | (24.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Diagnósticos da América Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Diagnósticos da América Margins & Growth Rates
Diagnósticos da América's revenue in the last 12 month declined by (12%).
Diagnósticos da América's revenue per employee in the last FY averaged $0.1M.
Diagnósticos da América's rule of 40 is 10% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Diagnósticos da América's rule of X is (8%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Diagnósticos da América Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (12%) | XXX | (28%) | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | (7%) | XXX | 5% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 10% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (8%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 21% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 21% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Diagnósticos da América Public Comps
See public comps and valuation multiples for other Hospitals & Clinics and Laboratory Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Butterfly Network | XXX | XXX | XXX | XXX | XXX | XXX |
| Clinica Baviera | XXX | XXX | XXX | XXX | XXX | XXX |
| Novogene | XXX | XXX | XXX | XXX | XXX | XXX |
| BioLife Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| Rhoen Klinikum | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Diagnósticos da América M&A Activity
Diagnósticos da América acquired XXX companies to date.
Last acquisition by Diagnósticos da América was on XXXXXXXX, XXXXX. Diagnósticos da América acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Diagnósticos da América
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDiagnósticos da América Investment Activity
Diagnósticos da América invested in XXX companies to date.
Diagnósticos da América made its latest investment on XXXXXXXX, XXXXX. Diagnósticos da América invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Diagnósticos da América
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Diagnósticos da América
| When was Diagnósticos da América founded? | Diagnósticos da América was founded in 1961. |
| Where is Diagnósticos da América headquartered? | Diagnósticos da América is headquartered in Brazil. |
| How many employees does Diagnósticos da América have? | As of today, Diagnósticos da América has over 18K employees. |
| Is Diagnósticos da América publicly listed? | Yes, Diagnósticos da América is a public company listed on B3. |
| What is the stock symbol of Diagnósticos da América? | Diagnósticos da América trades under DASA3 ticker. |
| When did Diagnósticos da América go public? | Diagnósticos da América went public in 2004. |
| Who are competitors of Diagnósticos da América? | Diagnósticos da América main competitors are Butterfly Network, Clinica Baviera, Novogene, BioLife Solutions. |
| What is the current market cap of Diagnósticos da América? | Diagnósticos da América's current market cap is $957M. |
| What is the current revenue of Diagnósticos da América? | Diagnósticos da América's last 12 months revenue is $2B. |
| What is the current revenue growth of Diagnósticos da América? | Diagnósticos da América revenue growth (NTM/LTM) is (12%). |
| What is the current EV/Revenue multiple of Diagnósticos da América? | Current revenue multiple of Diagnósticos da América is 1.2x. |
| Is Diagnósticos da América profitable? | Yes, Diagnósticos da América is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Diagnósticos da América? | Diagnósticos da América's last 12 months EBITDA is $431M. |
| What is Diagnósticos da América's EBITDA margin? | Diagnósticos da América's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Diagnósticos da América? | Current EBITDA multiple of Diagnósticos da América is 5.4x. |
| What is the current FCF of Diagnósticos da América? | Diagnósticos da América's last 12 months FCF is $101M. |
| What is Diagnósticos da América's FCF margin? | Diagnósticos da América's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Diagnósticos da América? | Current FCF multiple of Diagnósticos da América is 23.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.